APO Research
Talk to an analyst

APO RESEARCH · REPORT

Avanafil Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Avanafil Tablets Market Outlook and Growth Opportunities 2026

23 December 2025197 pages

Choose your research edition.

Industry ResearchAvanafil Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Avanafil Tablets Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Avanafil Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avanafil Tablets Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Avanafil Tablets Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Avanafil Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Avanafil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Avanafil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Avanafil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Avanafil Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Avanafil Tablets market include VIVUS, Sanofi, Huilun Pharmaceutical, Haisco Pharmaceutical, Menarini Group, JW Pharmaceutical, Endo International and Auxilium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Avanafil Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Avanafil Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Avanafil Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Avanafil Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Avanafil Tablets Segment by Company

VIVUS

Sanofi

Huilun Pharmaceutical

Haisco Pharmaceutical

Menarini Group

JW Pharmaceutical

Endo International

Auxilium Pharmaceuticals

Avanafil Tablets Segment by Type

50 mg

100 mg

200 mg

Avanafil Tablets Segment by Application

18-45 Years Old

46-60 Years Old

Other

Avanafil Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Avanafil Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Avanafil Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Avanafil Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Avanafil Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avanafil Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avanafil Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avanafil Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Avanafil Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Avanafil Tablets industry.

Chapter 3: Detailed analysis of Avanafil Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Avanafil Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Avanafil Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Avanafil Tablets Industry Trends Table 2. Avanafil Tablets Industry Drivers Table 3. Avanafil Tablets Industry Opportunities and Challenges Table 4. Avanafil Tablets Industry Restraints Table 5. Global Avanafil Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Avanafil Tablets Revenue Share by Company (2021-2026) Table 7. Global Avanafil Tablets Sales Volume by Company (kg) & (2021-2026) Table 8. Global Avanafil Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Avanafil Tablets Average Price (USD/g) of Company (2021-2026) Table 10. Global Avanafil Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Avanafil Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Avanafil Tablets Company, Product Type & Application Table 13. Global Avanafil Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Avanafil Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50 mg Table 18. Significant Companies of 100 mg Table 19. Significant Companies of 200 mg Table 20. Global Avanafil Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global Avanafil Tablets Sales Volume by Type (2021-2026) & (kg) Table 22. Global Avanafil Tablets Sales Volume by Type (2027-2032) & (kg) Table 23. Global Avanafil Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Avanafil Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Avanafil Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Avanafil Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Avanafil Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Avanafil Tablets Sales Value Share by Type (2021-2026) Table 29. Global Avanafil Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of 18-45 Years Old Table 31. Significant Companies of 46-60 Years Old Table 32. Significant Companies of Other Table 33. Global Avanafil Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 34. Global Avanafil Tablets Sales Volume by Application (2021-2026) & (kg) Table 35. Global Avanafil Tablets Sales Volume by Application (2027-2032) & (kg) Table 36. Global Avanafil Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Avanafil Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Avanafil Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Avanafil Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Avanafil Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Avanafil Tablets Sales Value Share by Application (2021-2026) Table 42. Global Avanafil Tablets Sales Value Share by Application (2027-2032) Table 43. Global Avanafil Tablets Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 44. Global Avanafil Tablets Sales by Region (2021-2026) & (kg) Table 45. Global Avanafil Tablets Sales Market Share by Region (2021-2026) Table 46. Global Avanafil Tablets Sales by Region (2027-2032) & (kg) Table 47. Global Avanafil Tablets Sales Market Share by Region (2027-2032) Table 48. Global Avanafil Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Avanafil Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Avanafil Tablets Sales Value Share by Region (2021-2026) Table 51. Global Avanafil Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Avanafil Tablets Sales Value Share by Region (2027-2032) Table 53. Global Avanafil Tablets Market Average Price (USD/g) by Region (2021-2026) Table 54. Global Avanafil Tablets Market Average Price (USD/g) by Region (2027-2032) Table 55. Global Avanafil Tablets Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 56. Global Avanafil Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Avanafil Tablets Sales by Country (2021-2026) & (kg) Table 58. Global Avanafil Tablets Sales Market Share by Country (2021-2026) Table 59. Global Avanafil Tablets Sales by Country (2027-2032) & (kg) Table 60. Global Avanafil Tablets Sales Market Share by Country (2027-2032) Table 61. Global Avanafil Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Avanafil Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Avanafil Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Avanafil Tablets Sales Value Market Share by Country (2027-2032) Table 65. VIVUS Company Information Table 66. VIVUS Business Overview Table 67. VIVUS Avanafil Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 68. VIVUS Avanafil Tablets Product Portfolio Table 69. VIVUS Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Avanafil Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 73. Sanofi Avanafil Tablets Product Portfolio Table 74. Sanofi Recent Development Table 75. Huilun Pharmaceutical Company Information Table 76. Huilun Pharmaceutical Business Overview Table 77. Huilun Pharmaceutical Avanafil Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 78. Huilun Pharmaceutical Avanafil Tablets Product Portfolio Table 79. Huilun Pharmaceutical Recent Development Table 80. Haisco Pharmaceutical Company Information Table 81. Haisco Pharmaceutical Business Overview Table 82. Haisco Pharmaceutical Avanafil Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 83. Haisco Pharmaceutical Avanafil Tablets Product Portfolio Table 84. Haisco Pharmaceutical Recent Development Table 85. Menarini Group Company Information Table 86. Menarini Group Business Overview Table 87. Menarini Group Avanafil Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 88. Menarini Group Avanafil Tablets Product Portfolio Table 89. Menarini Group Recent Development Table 90. JW Pharmaceutical Company Information Table 91. JW Pharmaceutical Business Overview Table 92. JW Pharmaceutical Avanafil Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 93. JW Pharmaceutical Avanafil Tablets Product Portfolio Table 94. JW Pharmaceutical Recent Development Table 95. Endo International Company Information Table 96. Endo International Business Overview Table 97. Endo International Avanafil Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 98. Endo International Avanafil Tablets Product Portfolio Table 99. Endo International Recent Development Table 100. Auxilium Pharmaceuticals Company Information Table 101. Auxilium Pharmaceuticals Business Overview Table 102. Auxilium Pharmaceuticals Avanafil Tablets Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 103. Auxilium Pharmaceuticals Avanafil Tablets Product Portfolio Table 104. Auxilium Pharmaceuticals Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Avanafil Tablets Distributors List Table 108. Avanafil Tablets Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Avanafil Tablets Product Image Figure 2. Global Avanafil Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avanafil Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Avanafil Tablets Sales (2021-2032) & (kg) Figure 5. Global Avanafil Tablets Sales Average Price (USD/g) & (2021-2032) Figure 6. Global Avanafil Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50 mg Image Figure 10. 100 mg Image Figure 11. 200 mg Image Figure 12. Global Avanafil Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global Avanafil Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Avanafil Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Avanafil Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Avanafil Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Avanafil Tablets Sales Value Share by Type (2021-2032) Figure 18. 18-45 Years Old Image Figure 19. 46-60 Years Old Image Figure 20. Other Image Figure 21. Global Avanafil Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Avanafil Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Avanafil Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Avanafil Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Avanafil Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Avanafil Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Avanafil Tablets Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 28. Global Avanafil Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Avanafil Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Avanafil Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Avanafil Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Avanafil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Avanafil Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Avanafil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Avanafil Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Avanafil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Avanafil Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Avanafil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Avanafil Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Avanafil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Avanafil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Avanafil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Avanafil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Avanafil Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Avanafil Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg
  • 100 mg
  • 200 mg
Applications
  • 18-45 Years Old
  • 46-60 Years Old
  • Other
Companies covered
  • VIVUS
  • Sanofi
  • Huilun Pharmaceutical
  • Haisco Pharmaceutical
  • Menarini Group
  • JW Pharmaceutical
  • Endo International
  • Auxilium Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Avanafil Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Avanafil Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Avanafil Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Avanafil Tablets Market Dynamics
  1. 2.1 Avanafil Tablets Industry Trends
  2. 2.2 Avanafil Tablets Industry Drivers
  3. 2.3 Avanafil Tablets Industry Opportunities and Challenges
  4. 2.4 Avanafil Tablets Industry Restraints
3 Avanafil Tablets Market by Company
  1. 3.1 Global Avanafil Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Avanafil Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Avanafil Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Avanafil Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Avanafil Tablets Company Ranking (2024-2026)
  6. 3.6 Global Avanafil Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Avanafil Tablets Company Product Type and Application
  8. 3.8 Global Avanafil Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Avanafil Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Avanafil Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Avanafil Tablets Market by Type
  1. 4.1 Avanafil Tablets Type Introduction
  2. 4.1.1 50 mg
  3. 4.1.2 100 mg
  4. 4.1.3 200 mg
  5. 4.2 Global Avanafil Tablets Sales Volume by Type
  6. 4.2.1 Global Avanafil Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Avanafil Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Avanafil Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Avanafil Tablets Sales Value by Type
  10. 4.3.1 Global Avanafil Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Avanafil Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Avanafil Tablets Sales Value Share by Type (2021-2032)
5 Avanafil Tablets Market by Application
  1. 5.1 Avanafil Tablets Application Introduction
  2. 5.1.1 18-45 Years Old
  3. 5.1.2 46-60 Years Old
  4. 5.1.3 Other
  5. 5.2 Global Avanafil Tablets Sales Volume by Application
  6. 5.2.1 Global Avanafil Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Avanafil Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Avanafil Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Avanafil Tablets Sales Value by Application
  10. 5.3.1 Global Avanafil Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Avanafil Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Avanafil Tablets Sales Value Share by Application (2021-2032)
6 Avanafil Tablets Regional Sales and Value Analysis
  1. 6.1 Global Avanafil Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Avanafil Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Avanafil Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Avanafil Tablets Sales by Region (2027-2032)
  5. 6.3 Global Avanafil Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Avanafil Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Avanafil Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Avanafil Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Avanafil Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Avanafil Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Avanafil Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Avanafil Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Avanafil Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Avanafil Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Avanafil Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Avanafil Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Avanafil Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Avanafil Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Avanafil Tablets Sales Value Share by Country, 2025 VS 2032
7 Avanafil Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Avanafil Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Avanafil Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Avanafil Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Avanafil Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Avanafil Tablets Sales by Country (2027-2032)
  6. 7.4 Global Avanafil Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Avanafil Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Avanafil Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Avanafil Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Avanafil Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Avanafil Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Avanafil Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Avanafil Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Avanafil Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Avanafil Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Avanafil Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Avanafil Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Avanafil Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Avanafil Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Avanafil Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Avanafil Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Avanafil Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Avanafil Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Avanafil Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Avanafil Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Avanafil Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Avanafil Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Avanafil Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Avanafil Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Avanafil Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Avanafil Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Avanafil Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Avanafil Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Avanafil Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Avanafil Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Avanafil Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Avanafil Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Avanafil Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 VIVUS
  2. 8.1.1 VIVUS Company Information
  3. 8.1.2 VIVUS Business Overview
  4. 8.1.3 VIVUS Avanafil Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 VIVUS Avanafil Tablets Product Portfolio
  6. 8.1.5 VIVUS Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Avanafil Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Avanafil Tablets Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Huilun Pharmaceutical
  14. 8.3.1 Huilun Pharmaceutical Company Information
  15. 8.3.2 Huilun Pharmaceutical Business Overview
  16. 8.3.3 Huilun Pharmaceutical Avanafil Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Huilun Pharmaceutical Avanafil Tablets Product Portfolio
  18. 8.3.5 Huilun Pharmaceutical Recent Developments
  19. 8.4 Haisco Pharmaceutical
  20. 8.4.1 Haisco Pharmaceutical Company Information
  21. 8.4.2 Haisco Pharmaceutical Business Overview
  22. 8.4.3 Haisco Pharmaceutical Avanafil Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Haisco Pharmaceutical Avanafil Tablets Product Portfolio
  24. 8.4.5 Haisco Pharmaceutical Recent Developments
  25. 8.5 Menarini Group
  26. 8.5.1 Menarini Group Company Information
  27. 8.5.2 Menarini Group Business Overview
  28. 8.5.3 Menarini Group Avanafil Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Menarini Group Avanafil Tablets Product Portfolio
  30. 8.5.5 Menarini Group Recent Developments
  31. 8.6 JW Pharmaceutical
  32. 8.6.1 JW Pharmaceutical Company Information
  33. 8.6.2 JW Pharmaceutical Business Overview
  34. 8.6.3 JW Pharmaceutical Avanafil Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 JW Pharmaceutical Avanafil Tablets Product Portfolio
  36. 8.6.5 JW Pharmaceutical Recent Developments
  37. 8.7 Endo International
  38. 8.7.1 Endo International Company Information
  39. 8.7.2 Endo International Business Overview
  40. 8.7.3 Endo International Avanafil Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Endo International Avanafil Tablets Product Portfolio
  42. 8.7.5 Endo International Recent Developments
  43. 8.8 Auxilium Pharmaceuticals
  44. 8.8.1 Auxilium Pharmaceuticals Company Information
  45. 8.8.2 Auxilium Pharmaceuticals Business Overview
  46. 8.8.3 Auxilium Pharmaceuticals Avanafil Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Auxilium Pharmaceuticals Avanafil Tablets Product Portfolio
  48. 8.8.5 Auxilium Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Avanafil Tablets Value Chain Analysis
  2. 9.1.1 Avanafil Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Avanafil Tablets Sales Mode & Process
  6. 9.2 Avanafil Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Avanafil Tablets Distributors
  9. 9.2.3 Avanafil Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst